Huixiang Powder Veterinary Grade API is a dry botanical active pharmaceutical ingredient derived from the dried ripe fruit of Foeniculum vulgare Mill. The product is supplied in three standard models: HX-VAPI-80M, HX-VAPI-40M, and HX-VAPI-IP. HX-VAPI-80M is milled to D90 ≤ 75 µm and is released for tablets, capsules, powders, granules, and premixes. HX-VAPI-40M is milled to D90 ≤ 40 µm for suspensions and oral solutions. HX-VAPI-IP is milled to D90 ≤ 25 µm and is reserved for injection extraction lines. Release limits include loss on drying ≤ 5.0% at 105°C for 4 h, total ash ≤ 6.0%, acid-insoluble ash ≤ 1.0%, trans-anethole ≥ 1.5% by GC-FID, and total essential oil ≥ 2.0 mL/100 g. Heavy metals are controlled to lead ≤ 10 mg/kg, cadmium ≤ 1 mg/kg, arsenic ≤ 5 mg/kg, and mercury ≤ 0.1 mg/kg by ICP-MS. Aflatoxin B1 is limited to ≤ 5 µg/kg. Microbial release testing follows USP <2021> and ISO 6579-1:2017; HX-VAPI-80M has total aerobic microbial count ≤ 10³ CFU/g, total yeast and mold count ≤ 10² CFU/g, absence of Escherichia coli per 1 g, and absence of Salmonella per 25 g.

What Does a Pharmacopoeial Identity Panel Require for Botanical Veterinary Materials?

Identity is not established by a single marker. The current CPV 2020 monograph for Fennel fruit and the Ph. Eur. 11.5 monograph for Foeniculus vulgare subsp. vulgare require orthogonal identification: macroscopic and microscopic characters, thin-layer chromatography against a reference extract, and a GC or GC-MS positive for trans-anethole, fenchone, and estragole. A release batch is considered misidentified if the TLC band at the R_f corresponding to trans-anethole is absent or if the GC area percentage of trans-anethole falls below the method-specific acceptance window.

Heavy metals are tested by inductively coupled plasma mass spectrometry following microwave digestion, with acceptance limits aligned to USP <2232> and ICH Q3D veterinary-relevant limits. Pesticide residues are screened by USP <561> Category 2 procedures. Aflatoxin B1 is confirmed by immunochemical cleanup with LC-MS/MS. Published data for this specific botanical configuration is limited for multi-year residue variability, so release testing retains full quantitative pesticide screens rather than reduced monitoring.

Granulation and Premix Carrier Selection Within Defined Shear Windows

Wet granulation with this API begins with pre-blending at 1:5 to 1:10 ratios against lactose monohydrate or microcrystalline cellulose before high-shear addition of purified water or a 5% povidone K30 binder solution. Production-scale high-shear mixers with impeller speed 120–180 rpm and chopper speed 1,000–1,500 rpm yield granulates with bulk density 0.48–0.58 g/cm³. Drying is maintained at 50–60°C because trans-anethole is volatile above 65°C; a 16-station rotary tablet press feed-line trial recorded capping and sticking when granulate moisture exceeded 6.5% or when D90 exceeded 75 µm. Granules should be re-milled through 20 mesh after drying to reduce oversize and preserve disintegration time. These boundaries are revalidated after any change in source lot because botanical particle morphology shifts with harvest region and residual moisture.

For feed premix lines, the API is step-diluted with defatted rice bran or calcium carbonate at 1:10, then 1:100 geometric dilutions to achieve content uniformity within ±10% of label claim in a ribbon mixer operated at 60–80% nominal capacity. Bulk powder angle of repose must remain ≤ 40° to avoid rat-holing in dosing augers. Warehousing above 60% relative humidity is an operational incompatibility because moisture gain above 5.0% increases stickiness and particle agglomeration.

Direct compression trials on a 30-station rotary press with 9 mm biconvex tooling used 30% Huixiang Powder, 56% microcrystalline cellulose, 10% lactose monohydrate, 3% croscarmellose sodium, and 0.5% magnesium stearate. Tablets produced at 8–12 kN compression force showed hardness 45–75 N, friability ≤ 1.0%, and disintegration ≤ 15 min in purified water at 37°C by USP <701> apparatus. Capsule filling on a 100,000 capsule/hour machine requires sieving through 30 mesh and controlling fill weight to ±5%; dosator bridging occurs if angle of repose exceeds 40° or if moisture exceeds 5.0%. Content uniformity testing is performed according to USP <905>, with acceptance value ≤ 15.

Injectable manufacture from crude botanical powder is not direct. The API must be extracted in purified water, clarified by 0.45 µm filtration, cooled to 4–8°C for tannin and polysaccharide precipitation, then re-filtered through 0.22 µm sterilizing-grade membrane. Residual solids after aqueous extraction are typically 15–25% of the initial charged mass; therefore process output is lower than for synthetic injectables. Endotoxin is controlled after extraction because the crude powder is not inherently pyrogen-free. A veterinary injectable batch must meet USP <85> bacterial endotoxin and USP <71> sterility test requirements. Endotoxin removal is not achieved by the 0.22 µm membrane alone; the extraction stream is treated with activated carbon or depth filtration before final filtration. After depyrogenation, the aqueous extract shows pH 5.0–6.5, osmolality 280–320 mOsm/kg, and total solids 3–8% w/v depending on starting extract ratio. Injectable formulations should not combine the extract with cationic preservatives such as benzalkonium chloride at concentrations above 0.02% without compatibility testing because tannin–cation complexes can form visible precipitates within 24 h at 2–8°C.

When the Same Powder Moves from Tablets to Premixes and Solutions

The formulation route changes the exposure of the API to water activity, shear, temperature, and filtration. In tablets and capsules, the primary risk is physical segregation because the botanical powder has a wide particle-size distribution and low bulk density. In granules, the primary risk is volatile loss in wet mass drying. In premixes, the primary risk is cross-contamination and carryover in feed mills; dedicated lines or verified cleaning between batches of coccidiostats and antibiotics are required when the premix is not medicated. Feed premix lines handling this botanical API after ionophore coccidiostats require cleaning validation because carryover above 0.1% of the previous medicated premix can exceed species-specific tolerance. A 12-bin automated batching system with air sweep and wash-out cycles was used to reduce carryover below 0.05%; the API is not compatible with alkaline mineral premixes above pH 9 due to browning and oxidation of phenolic constituents.

In solutions and suspensions, the primary risk is microbial growth and sedimentation. The API does not dissolve completely in aqueous vehicles; it forms a suspension that requires thickening agents such as xanthan gum at 0.2–0.5% w/v to maintain redispersibility over 24 h. Oral solutions should contain preservatives validated according to USP <51> effectiveness testing. Reconstitution of HX-VAPI-40M into a 10% w/v suspension with 0.3% xanthan gum yields a sedimentation volume ratio ≥ 0.85 at 24 h under ambient storage.

Validation of the GC-FID assay for trans-anethole followed ICH Q2(R1) parameters: specificity against estragole and fenchone; linearity over 0.5–3.0% w/w with correlation coefficient ≥ 0.9995; repeatability relative standard deviation ≤ 1.0% for six injections; intermediate precision RSD ≤ 2.0% across two analysts and three days; accuracy recovery 98.0–102.0% at three fortification levels. The limit of quantification was 0.05% w/w. Water determination by Karl Fischer titration per USP <921> Method I overcomes interference from volatile oils that distorts loss on drying. Heavy metals by ICP-MS used a 0.3 g sample digested in 8 mL nitric acid and 2 mL hydrogen peroxide; the method is calibrated from 0.5 µg/L to 100 µg/L.

Stability of the dry powder in sealed aluminum-laminated bags is evaluated under 25°C ± 2°C/60% RH ± 5% RH and 30°C ± 2°C/65% RH ± 5% RH storage. At 12 months, trans-anethole retention is typically ≥ 95% of initial when headspace oxygen is below 3%. At 40°C ± 2°C/75% RH ± 5% RH, moisture gain above 5.0% and microbial outgrowth risk increase. Bags are re-sealed after each dispensing event; open-bag storage in feed mill environments above 60% relative humidity causes moisture-related caking and dosator filling deviation.

Differences from other product classes are operational. Compared with fennel essential oil, the powder retains non-volatile flavonoids, phenolic glycosides, and water-soluble polysaccharides; essential oil contains mainly the volatile fraction and lacks the full botanical residue. Compared with synthetic antispasmodics or digestive stimulants, the powder has a slower onset and multi-constituent binding rather than a single receptor target. Compared with food-grade fennel powder, the veterinary API grade adds veterinary pharmacopoeial identity, veterinary microbial limits, aflatoxin control, and batch traceability to source lot. Compared with hydroalcoholic extract granules, the powder has lower active-marker concentration per unit mass but avoids residual solvent burdens and retains volatile and non-volatile components in the same matrix.